DexCom (DXCM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at ...

After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus ...

DexCom Inc. closed 39.31% below its 52-week high of $132.26, which the company reached on May 17th.

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...

DexCom Inc. closed 38.36% below its 52-week high of $132.26, which the company reached on May 17th.

DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins. Check out why I am lowering my rating on DXCM from buy to hold.

I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...

Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with ...

Glucose tracking is a natural part of Oura’s $75 million investment from Dexcom.

Oura Ring is the best smart ring on the market ( according to Mashable's tests, at least), and its holistic approach to ...